Buzzberg Cup Live
#989 Alpha Score 2.3

Lee Yeok-jin

Deputy
· tracked since Jun 2026
989
BUZZBERG The leaderboard is ranked by Alpha Score, which weighs a speaker's average return, their number of calls, and reputation — a credibility rating of the source that can only raise a score, never lower it. Read the FAQ
Alpha Score 2.3
Calls
18
Win Rate
11.1%
return
-22.9%
Calls 18 5 Posts tracked · 0.1/day
Calls
7d 0
30d 14
90d 18
Best Calls
006360.KS Long +11.4%
068270.KS Long +0.1%
Worst Calls
307950.KS Long -60.5%
011070.KS Long -59.9%
018260.KS Long -47.7%
Most Mentioned
005930.KS ×2
BNO ×1
XBI ×1
Recent Calls
MU Long 1 week ago
005935.KS Long 1 week ago
247540.KQ Long 2 weeks ago
Win Rate 11% Long 17 Short 1
Win Rate
7d 24%
30d 25%
90d
Average Return -22.9% Long Return -23.1% Short Return -19.0%
Average Return
7d -9.8%
30d -33.3%
90d
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jun 29
$323500.00
-21.2%
Memory semiconductor cycle to accelerate further
The memory semiconductor cycle is far from over and is entering a highly exciting phase. Samsung Electronics’ Q2 earnings could surprise near 100 trillion KRW (approx. double Micron on a currency-adjusted basis), making its valuation extremely attractive. Even if memory prices (P) eventually peak, volume (Q) expansion driven by HBM and AI demand will keep revenue and operating profit structurally higher, so a return to the old trough levels is very unlikely. The setup offers 2–3 years of upside potential with limited downside risk.
AI Memory
Long
Jul 10
$197300.00
-12.8%
Samsung preferred discount abnormally wide
The discount on Samsung Electronics preferred shares has widened to 30% versus the normal 10%, offering a mean-reversion opportunity as the gap eventually narrows back to historical levels.
AI Memory
Long
Jul 10
$983.14
-14.2%
Micron could surpass Meta, huge upside
Perplexity CEO predicts Micron's market cap could surpass Meta, implying Micron must rise 35%+ and driving massive upside for the AI memory supply chain.
AI Memory
Long
Jun 29
$152300.00
-26.2%
Buy KOSDAQ leaders on policy rotation.
With oil prices declining and rate hike fears peaking, money will rotate into KOSDAQ biotech and 2nd batteries. The CSD policy will amplify this rotation. Alteogen, the largest KOSDAQ stock, will lead this move.
Critical Minerals
Long
Jun 29
$2594000.00
-29.0%
Memory semiconductor cycle to accelerate further
The memory semiconductor cycle is far from over and is entering a highly exciting phase. Samsung Electronics’ Q2 earnings could surprise near 100 trillion KRW (approx. double Micron on a currency-adjusted basis), making its valuation extremely attractive. Even if memory prices (P) eventually peak, volume (Q) expansion driven by HBM and AI demand will keep revenue and operating profit structurally higher, so a return to the old trough levels is very unlikely. The setup offers 2–3 years of upside potential with limited downside risk.
AI Memory
Long
Jun 29
$485000.00
-12.4%
Hyundai Motor oversold, poised to rebound
Hyundai Motor and the broader KOSPI non-semiconductor large-cap group have been excessively sold off due to the black-hole effect of semiconductor single-stock leveraged ETFs. Hyundai Motor is now in a technical oversold condition, and valuations have retreated into the average band. With semiconductors pausing, non-semiconductor names have room to rebound. Hyundai Motor is a specific expression of this valuation and technical bounce play.
Autos & EV
Long
Jun 29
$24500.00
+11.4%
GS Construction to gain from data center boom
Cloud data center construction capex is set to rise sharply next year. Companies that build and operate data centers, such as GS Construction, are well-positioned to benefit from the edge data center trend, where existing logistics centers or vacant IT factories are being converted into data centers.
Construction & Infrastructure
Long
Jun 29
$175600.00
+0.1%
Korean biotech to benefit from oil decline
Falling oil is historically a strong inverse driver for biotech. US biotech ETFs (XBI, IBB) are already breaking out to new highs, while Korean biotech has been deeply oversold and is just beginning to recover. With oil heading lower, Korean biotech equities are poised for a significant catch-up rally, supported by attractive valuations, the KOSDAQ promotion policy, and sector themes like obesity and ADC (antibody-drug conjugates).
Pharma & Biotech
Long
Jun 29
$376000.00
-26.5%
Alteogen earnings and royalty cycle rising
Falling oil is historically a strong inverse driver for biotech. US biotech ETFs (XBI, IBB) are already breaking out to new highs, while Korean biotech has been deeply oversold and is just beginning to recover. With oil heading lower, Korean biotech equities are poised for a significant catch-up rally, supported by attractive valuations, the KOSDAQ promotion policy, and sector themes like obesity and ADC (antibody-drug conjugates).
Pharma & Biotech
Long
Jun 29
$1414000.00
-1.3%
Korean biotech to benefit from oil decline
Falling oil is historically a strong inverse driver for biotech. US biotech ETFs (XBI, IBB) are already breaking out to new highs, while Korean biotech has been deeply oversold and is just beginning to recover. With oil heading lower, Korean biotech equities are poised for a significant catch-up rally, supported by attractive valuations, the KOSDAQ promotion policy, and sector themes like obesity and ADC (antibody-drug conjugates).
Pharma & Biotech
Short
Jun 29
$105.48
-19.0%
Crude oil price to decline further
Crude oil prices will continue to decline. The real economy is weak, and Europe is experiencing a record heatwave that will sharply reduce heating demand. Additionally, if Iranian crude starts flowing, oil could fall further, potentially creating a Goldilocks environment. Oil is already declining, and the 70-dollar level should break to the downside.
Commodities
Long
Jun 29
$155.38
-0.8%
Korean biotech to benefit from oil decline
Falling oil is historically a strong inverse driver for biotech. US biotech ETFs (XBI, IBB) are already breaking out to new highs, while Korean biotech has been deeply oversold and is just beginning to recover. With oil heading lower, Korean biotech equities are poised for a significant catch-up rally, supported by attractive valuations, the KOSDAQ promotion policy, and sector themes like obesity and ADC (antibody-drug conjugates).
Thematic ETFs
Long
Jun 22
$1941000.00
-37.6%
SK Square outperforms SK Hynix
SK Square, the holding company of SK Hynix, offers superior upside compared to direct SK Hynix because of its persistent NAV discount, the upcoming SK Hynix ADR listing and potential massive shareholder returns, and SK Square's own 20% share cancellation plan. The passive fund buying constraint on SK Hynix will push money into SK Square, creating alpha.
Capital Markets
Long
Jun 22
$29295.00
-17.1%
Buy Korean semiconductor equipment sector
The Korean semiconductor equipment and materials sector (소부장) will continue to outperform because the multi-year capex upcycle from Samsung, SK Hynix, and TSMC is accelerating from 3Q onward, and the KOSDAQ premium league reform will direct institutional flows specifically toward profitable equipment names, sustaining the sector's momentum.
Thematic ETFs
Long
Jun 01
$2043000.00
-37.5%
Substrate shortage drives earnings
FCBGA substrates are in severe shortage, with Samsung Electro-Mechanics and LG Innotek benefiting from multi-year demand. Supply will not ease until late next year, driving earnings upgrades.
AI Hardware
Showing 15 of 18 calls · sorted by mentions

Lee Yeok-jin has 18 trade ideas tracked on Buzzberg across 18 tickers since June 2026. Win rate 11% across 18 evaluated calls, average return -22.9%. Ranked #989 on the Buzzberg Alpha leaderboard. Most covered: 005930.KS, BNO, XBI.